Roberto Pineda II, MD
| Director, Keratorefractive Surgery Service | |
| Specialties: | Cornea and External Diseases Refractive Surgery |
| Phone Number: | 617-573-4393 |
| Fax: | 617-573-4300 |
| Location: |
243 Charles Street Boston, MA 02114 |
| Office Hours: | Mon. and Thurs. |
| Board Certification: | Ophthalmology |
| Medical School | University of Minnesota Medical School |
| Residency | Harvard Medical School, Mass. Eye and Ear (Ophthalmology) |
| Fellowship | Harvard Medical School, Mass. Eye and Ear (Cornea, External Diseases and Refractive Surgery) |
| Teaching Affiliation | Associate Professor in Ophthalmology, Harvard Medical School |
|
Biographical Profile:
Prior to his role as Director of Refractive Surgery on the Cornea Service at Mass. Eye and Ear, Dr. Pineda was the Division Chief of Ophthalmology at the Brigham and Women's Hospital and Director of the Anterior Segment Fellowship. He also helped establish and directed the Refractive Surgery Service for Harvard Vanguard Medical Associates. A pioneer in his field, he has brought new techniques and technology to Mass. Eye and Ear and the New England region, including conductive keratoplasty, Intacs with Intralase for keratoconus and DLEK, DSEK, and DALK (novel lamellar corneal transplantation). The recipient of numerous awards for his work as a physician, he also has garnered praise as an innovator and mentor. To date, he has co-authored four textbooks, published numerous papers, and continues to teach and lecture at national meetings. Clinical InterestsCornea disease, cataract, refractive surgery Research InterestsCornea disease, cataract, refractive surgery PublicationsFor a full publication list, please see his CV. A representative list (2006 - 2013) is available through www.pubmed.gov. Dastjerdi MH, Al-Arfaj KM, Nallasamy N, Hamrah P, Jurkunas UV, Pineda R 2nd, Pavan-Langston D, Dana R. Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol. 2009 Apr; 127(4): 381-9.
Page updated: April 15, 2013 |
|
